{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:16:16Z","timestamp":1788671776934,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmorwd.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Real World Data and Digital Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.esmorw.2025.100125","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T14:46:20Z","timestamp":1741963580000},"page":"100125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Observational study on the safety and effectiveness of SARS-CoV-2 vaccination in patients with lung cancer"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9674-5554","authenticated-orcid":false,"given":"E.","family":"Nadal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Estival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u00c1.","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Anto\u00f1anzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Diz-Ta\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Azcona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Baena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Cumplido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cerezo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"D\u00edaz-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Guirado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Mielgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Saig\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Vidales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmorw.2025.100125_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/10408363.2020.1783198","article-title":"The COVID-19 pandemic","volume":"57","author":"Ciotti","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.esmorw.2025.100125_bib2","article-title":"WHO chief declares end to COVID-19 as a global health emergency","year":"2023","journal-title":"UN News"},{"key":"10.1016\/j.esmorw.2025.100125_bib4","article-title":"Risk factors for mortality among lung cancer patients with covid-19 infection: a systematic review and meta-analysis","volume":"18","author":"Wu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.esmorw.2025.100125_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2021.05.014","article-title":"Lung cancer patients with COVID-19 in Spain: GRAVID study","volume":"157","author":"Provencio","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.esmorw.2025.100125_bib7","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.esmorw.2025.100125_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.esmorw.2025.100125_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315067","article-title":"The interplay of lung cancer, COVID-19, and vaccines","volume":"23","author":"Trivanovi\u0107","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.esmorw.2025.100125_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pds.3891","article-title":"Guidelines for good pharmacoepidemiology practice (GPP)","volume":"25","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.esmorw.2025.100125_bib11","first-page":"104907","article-title":"Real Decreto 957\/2020, de 3 de noviembre, por el que se regulan los estudios observacionales con medicamentos de uso humano","year":"2020","journal-title":"BOE-A-2020-14960"},{"key":"10.1016\/j.esmorw.2025.100125_bib12","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.esmorw.2025.100125_bib13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-Sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Statist"},{"key":"10.1016\/j.esmorw.2025.100125_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.21037\/tlcr.2019.08.05","article-title":"Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study)","volume":"8","author":"Provencio","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.esmorw.2025.100125_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.gaceta.2022.02.013","article-title":"Representativeness of the Spanish Thoracic Tumour Registry. Comparison of sociodemographic data with other national registries","volume":"36","author":"Candal-Pedreira","year":"2022","journal-title":"Gac Sanit"},{"key":"10.1016\/j.esmorw.2025.100125_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107323","article-title":"Immunogenicity of COVID-19 vaccines in lung cancer patients","volume":"184","author":"Provencio","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.esmorw.2025.100125_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/cancers15010137","article-title":"Immune response and effects of COVID-19 vaccination in patients with lung cancer\u2014COVID Lung Vaccine Study","volume":"15","author":"Hernandez","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.esmorw.2025.100125_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jtho.2021.10.015","article-title":"Efficacy of severe acute respiratory syndrome coronavirus-2 vaccine in patients with thoracic cancer: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses","volume":"17","author":"Gounant","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.esmorw.2025.100125_bib20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/vaccines10040618","article-title":"Assessment of seroconversion after SARS-CoV-2 vaccination in patients with lung cancer","volume":"10","author":"Trontzas","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.esmorw.2025.100125_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccell.2022.04.012","article-title":"Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer","volume":"40","author":"Mack","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.esmorw.2025.100125_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2021.11.012","article-title":"Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy","volume":"166","author":"Bowes","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.esmorw.2025.100125_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2140549","article-title":"Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: a prospective multicenter cohort study","volume":"18","author":"Nakashima","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.esmorw.2025.100125_bib24","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jtho.2022.05.015","article-title":"Safety and immunogenicity of mRNA vaccines against severe acute respiratory syndrome coronavirus 2 in patients with lung cancer receiving immune checkpoint inhibitors: a multicenter observational study in Japan","volume":"17","author":"Hibino","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.esmorw.2025.100125_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.lungcan.2021.05.002","article-title":"Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis","volume":"157","author":"Lei","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.esmorw.2025.100125_bib26","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.3390\/cancers14225706","article-title":"COVID-19 and lung cancer survival: an updated systematic review and meta-analysis","volume":"14","author":"Oldani","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.esmorw.2025.100125_bib27","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1473-3099(20)30195-X","article-title":"Real estimates of mortality following COVID-19 infection","volume":"20","author":"Baud","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.esmorw.2025.100125_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.annonc.2021.01.068","article-title":"The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate","volume":"32","author":"Garassino","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmorw.2025.100125_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13045-021-01046-w","article-title":"COVID-19 vaccines for patients with cancer: benefits likely outweigh risks","volume":"14","author":"Hwang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.esmorw.2025.100125_bib30","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/vaccines9121387","article-title":"A systematic review on COVID-19 vaccine strategies, their effectiveness, and issues","volume":"9","author":"Khandker","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.esmorw.2025.100125_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-069989","article-title":"Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis","volume":"377","author":"Au","year":"2022","journal-title":"Br Med J"},{"key":"10.1016\/j.esmorw.2025.100125_bib32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/vaccines11050969","article-title":"Serological response to SARS-CoV-2 after COVID-19 vaccination in lung cancer patients: short review","volume":"11","author":"Rodilla","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.esmorw.2025.100125_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.40364","article-title":"Analysis of COVID-19 vaccine type and adverse effects following vaccination","volume":"4","author":"Beatty","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.esmorw.2025.100125_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12291-021-00968-z","article-title":"Adverse events reported from COVID-19 vaccine trials: a systematic review","volume":"36","author":"Kaur","year":"2021","journal-title":"Ind J Clin Biochem"},{"key":"10.1016\/j.esmorw.2025.100125_bib35","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/jth.15725","article-title":"Risk of venous thromboembolism after COVID-19 vaccination","volume":"20","author":"Houghton","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.esmorw.2025.100125_bib36","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaoncol.2021.2155","article-title":"Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer","volume":"7","author":"Massarweh","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.esmorw.2025.100125_bib37","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1470-2045(22)00202-9","article-title":"Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study","volume":"23","author":"Lee","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmorw.2025.100125_bib38","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2027160","article-title":"The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review","volume":"18","author":"Mohammed","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.esmorw.2025.100125_bib39","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection","volume":"386","author":"Hall","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.esmorw.2025.100125_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7032","article-title":"Survival and safety analysis of COVID-19 vaccine in Chinese patients with non-small cell lung cancer","volume":"13","author":"Xu","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.esmorw.2025.100125_bib41","article-title":"Differential survival among patients with cancer by COVID-19 vaccination status: an analysis of the ASCO COVID-19 registry","volume":"1","author":"Kirkwood","year":"2024","journal-title":"JCO Oncol Adv"}],"container-title":["ESMO Real World Data and Digital Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949820125000141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949820125000141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:53:39Z","timestamp":1788670419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949820125000141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":38,"alternative-id":["S2949820125000141"],"URL":"https:\/\/doi.org\/10.1016\/j.esmorw.2025.100125","relation":{},"ISSN":["2949-8201"],"issn-type":[{"value":"2949-8201","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Observational study on the safety and effectiveness of SARS-CoV-2 vaccination in patients with lung cancer","name":"articletitle","label":"Article Title"},{"value":"ESMO Real World Data and Digital Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmorw.2025.100125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100125"}}